Publications
- Oxidative DNA damage in bone marrow cells of patients with low-risk myelodysplastic syndrome2009 | First Faculty of Medicine
- Analysis of complex chromosomal rearrangements in adult patients with MDS and AML by multicolor FISH2007 | First Faculty of Medicine
- Are Fli1, EKLF, PU.1, HDM2 and TP53 factors implicated in refractory anemia and megakaryopoiesis in 5q- syndromePublication without faculty affiliation
- True monozomy of chromosome 5 is presumably not an isolated cytogenetic entity in myelodysplastic syndromes (MDS).Publication without faculty affiliation
- True monosomy of chromosome 5 is presumably not an isolated cytogenetic entity in MDSPublication without faculty affiliation
- Growth of myeloid progenitor cells CFU-GM in vitro is indicator of survival of patients with myelodysplasic syndromePublication without faculty affiliation
- Cryptic aberrations may allow more accurate prognostic classification of patients with myelodysplastic syndromes and clonal evolution2020 | First Faculty of Medicine
- Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin +/- prednisone addition to lenalidomide in refractory or relapsed patients)2018 | First Faculty of Medicine
- Komentář ke studii (Léčba esenciální trombocytemie v Evropě - studie EXELS s anagrelidem)2018 | First Faculty of Medicine
- Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes2016 | First Faculty of Medicine
Loading network view...